These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 7189510)

  • 1. [Dynamic blood glucose adjustment in diabetics in a closed loop system].
    Kruse-Jarres JD; Bresch M; Lehmann U; Letulé U; Vogel W
    Infusionsther Klin Ernahr; 1980 Feb; 7(1):25-34. PubMed ID: 7189510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood glucose monitoring and computer regulation by means of an artificial endocrine pancreas.
    Kruse-Jarres JD; Braun G; Naegele R; Bresch M; Lehmann U
    Horm Metab Res Suppl; 1979; (8):42-5. PubMed ID: 395088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Artificial pancreas: clinical and therapeutic value in 11 patients (author's transl)].
    Buysschaert M; Lambotte L; Lambert AE
    Nouv Presse Med; 1979 Jul 14-28; 8(32):2597-601. PubMed ID: 386266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a closed-loop artificial pancreas.
    Kraegen EW; Whiteside R; Bell D; Chia YO; Lazarus L
    Horm Metab Res Suppl; 1979; (8):38-42. PubMed ID: 395087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic study of the blood viscosity of insulin-dependent diabetics by means of an artificial pancreas.
    Drouin P; Rousselle D; Pointel JP; Voisin G; Stoltz JF; Clemens AH; Debry G
    Horm Metab Res Suppl; 1979; (8):107-10. PubMed ID: 395064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of an artificial endocrine pancreas in the management of the diabetic surgical patient.
    Kerner W; Beischer W; Herfarth C; Pfeiffer EF
    Horm Metab Res Suppl; 1979; (8):159-61. PubMed ID: 395073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas.
    Weinzimer SA; Steil GM; Swan KL; Dziura J; Kurtz N; Tamborlane WV
    Diabetes Care; 2008 May; 31(5):934-9. PubMed ID: 18252903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Artificial endocrine pancreas (author's transl)].
    Kruse-Jarres JD
    J Clin Chem Clin Biochem; 1979 Jul; 17(7):457-63. PubMed ID: 383880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical and diabetic research of the artificial extracorporeal pancreas].
    Mirouze J; Selam JL; Pham TC
    Nouv Presse Med; 1977 May; 6(21):1837-41. PubMed ID: 876830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control algorithms for artificial beta cell.
    Clemens AH
    Horm Metab Res Suppl; 1979; (8):35-8. PubMed ID: 395086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous postoperative blood glucose monitoring and control by artificial pancreas in patients having pancreatic resection: a prospective randomized clinical trial.
    Okabayashi T; Nishimori I; Yamashita K; Sugimoto T; Maeda H; Yatabe T; Kohsaki T; Kobayashi M; Hanazaki K
    Arch Surg; 2009 Oct; 144(10):933-7. PubMed ID: 19841361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The normalisation of blood sugar using a non-miniaturised artifical pancreas. Application for 24 hours in 7 insulin-dependent diabetics (author's transl)].
    Slama G; Klein JC; Tardieu MC; Tchobroutsky G
    Nouv Presse Med; 1977 Jun; 6(26):2309-13. PubMed ID: 887415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The artificial endocrine pancreas in clinical practice and research. The present position and future perspectives.
    Marena S; Imperiale G; Pagano G
    Panminerva Med; 1993 Jun; 35(2):67-74. PubMed ID: 8414626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The artificial beta cell (Biostator) in the adjustment of instable diabetics--results after 20 months.
    Beyer J; Wolf E; Cordes U; Hassingen W
    Horm Metab Res Suppl; 1979; (8):127-31. PubMed ID: 395068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of an artificial B-cell in clinic and experimental medicine].
    Fischer U; Bruns W; Jutzi E; Ratzmann KP; Abel P; Bombor H; Salzsieder E; Freyse EJ
    Z Gesamte Inn Med; 1981 Jan; 36(1):19-26. PubMed ID: 7013292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Artificial pancreas: study methods and control of glycemia equilibrium in diabetic patients].
    Altomare E; Moulin JP; Vialettes B; Bourelly N; Vague P
    Boll Soc Ital Biol Sper; 1979 May; 55(10):961-6. PubMed ID: 508411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strict glycemic control in diabetic dogs with closed-loop intraperitoneal insulin infusion algorithm designed for an artificial endocrine pancreas.
    Matsuo Y; Shimoda S; Sakakida M; Nishida K; Sekigami T; Ichimori S; Ichinose K; Shichiri M; Araki E
    J Artif Organs; 2003; 6(1):55-63. PubMed ID: 14598126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The development of artificial endocrine pancreas. From bedside-, wearable-type to implantable one.
    Shichiri M; Kawamori R; Yamasaki Y
    Med Prog Technol; 1987; 12(1-2):39-50. PubMed ID: 3627019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The INCA system: a further step towards a telemedical artificial pancreas.
    Gómez EJ; Hernando Pérez ME; Vering T; Rigla Cros M; Bott O; García-Sáez G; Pretschner P; Brugués E; Schnell O; Patte C; Bergmann J; Dudde R; de Leiva A
    IEEE Trans Inf Technol Biomed; 2008 Jul; 12(4):470-9. PubMed ID: 18632327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous glucose monitoring and closed-loop systems.
    Hovorka R
    Diabet Med; 2006 Jan; 23(1):1-12. PubMed ID: 16409558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.